40 likes | 49 Views
The global lenalidomide drug market is anticipated to grow at a significant CAGR during the forecast period.
E N D
Global Lenalidomide Drug Market, Size, Share, Analysis Report & Forecast to 2026 Global Lenalidomide Drug Market Size, Growth Analysis Report, Forecast to 2027 Global Lenalidomide Drug Market Size, Growth Analysis Report, Forecast to 2027 Global Lenalidomide Drug Market: Report Based on Development, Scope, Share, Trends, Forecast to 2027 Global Lenalidomide Drug Market Trends | Segmentation, Outlook, Industry Report to 2021-2027 The global lenalidomide drug market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market is the increasing prevalence of myeloma cancer. According to American Cancer’s Society, in 2021, around 34,920 cases have been diagnosed with multiple myeloma, which is leading to increasing demand for lenalidomide drugs. Free Sample Copy @ https://www.omrglobal.com/request-sample/lenalidomide-drug- market This drug is used for the treatment of multiple myeloma, it is equivalent to thalidomide, however, have fewer side effects such as constipation, sedation, and neuropathy as compared
to thalidomide. This drug is used to treat anaemia in patients who are suffering from some kind of myeloma. This drug is also used to treat another disease referred to as mantle cell lymphoma. Even though the treatment for myeloma cancer has advanced rapidly over the years, this disease is still incurable. Myeloma cancer starts in the bone marrow, where the disease causes the antibody-producing cells to transform into cancerous myeloma cells, due to which the formation of abnormal antibodies takes place in the body. The lenalidomide is used in another treatment apart from multiple myeloma, such as myelodysplastic syndrome, and others. A Full Report of Global Lenalidomide Drug Market is Available at: https://www.omrglobal.com/industry-reports/lenalidomide-drug-market Lenalidomide is primarily used for the management of the myelodysplastic syndrome. In September 2021, Dr Reddy’s Laboratories launched the generic version of Lenalidomide known as Reddy- Lenalidomide in Canada. This drug will be used to treat patients who are diagnosed with transfusion-dependent anaemia due to the risk of myelodysplastic syndrome. There have been numerous drugs developed in recent years to treat multiple myeloma, due to which the total survival rate of patients suffering from multiple myeloma has increased as compared to previous years, while toxicity is one of the side effects which is restraining the growth of the lenalidomide market. Global Lenalidomide Drug Market – Segmentation By Type •5 mg capsule •10 mg capsule •15 mg capsule •25 mg capsule By Application •Multiple Myeloma •Myelodysplastic syndrome •Others Global Lenalidomide Drug Market – Segmentation by Region North America •United States •Canada Europe
•Germany •United Kingdom •France •Spain •Italy •Rest of Europe Asia-Pacific •China •Japan •India •Rest of Asia-Pacific Rest of the World Company Profiles •Celgene •SL Pharma For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/lenalidomide-drug-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com Contact no: +91 780-304-0404